Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-01 Sale | 2023-11-03 4:39 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 21,619 | $13.84 | $299,309 | 1,538,070 (Indirect Direct) | View |
| 2023-10-02 Sale | 2023-10-04 5:07 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 20,245 | $14.82 | $300,026 | 1,559,689 (Indirect Direct) | View |
| 2023-05-16 Sale | 2023-05-18 5:22 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 15,000 | $19.98 | $299,700 | 1,579,934 (Indirect Direct) | View |
| 2023-05-11 Sale | 2023-05-15 8:34 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 45,000 | $20.68 | $930,656 | 1,594,934 (Direct) | View |
| 2022-09-06 Sale | 2022-09-08 5:08 pm | EAGLE PHARMACEUTICALS INC. | EGRX | Edlin Richard A. Director | 6,800 | $30.99 | $210,732 | 22,600 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-28 Tax Withholding | 2024-03-01 4:40 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner | 2,119 | $6.27 | 1,453,244 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 8:23 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph CHIEF FINANCIAL OFFICER | 3,800 | $0 | 47,958 (Direct) | View |
| 2024-02-27 Tax Withholding | 2024-02-29 8:23 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph CHIEF FINANCIAL OFFICER | 1,589 | $6.44 | 47,958 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:44 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner | 12,950 | $0 | 1,455,363 (Direct) | View |
| 2024-02-27 Tax Withholding | 2024-02-29 4:44 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner | 3,154 | $6.44 | 1,455,363 (Direct) | View |
| 2024-02-02 Tax Withholding | 2024-02-06 5:09 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph CHIEF FINANCIAL OFFICER | 934 | $5.85 | 45,747 (Direct) | View |
| 2024-01-05 Tax Withholding | 2024-01-09 5:01 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 735 | $5.13 | 46,681 (Direct) | View |
| 2024-01-05 Tax Withholding | 2024-01-09 5:00 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott 10% Owner | 4,322 | $5.13 | 1,533,748 (Direct) | View |
| 2023-12-21 Option Award | 2023-12-22 7:00 pm | N/A 2033-12-20 | EAGLE PHARMACEUTICALS INC. | EGRX | Graves Michael Interim Executive Chair & PEO | 293,000 | $0 | 293,000 (Direct) | View |
| 2023-12-18 Tax Withholding | 2023-12-20 4:34 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 452 | $4.76 | 47,416 (Direct) | View |
| 2023-10-27 Exercise | 2023-10-31 5:41 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Graves Michael Director | 9,360 | $4.94 | 10,360 (Direct) | View |
| 2023-10-27 Exercise | 2023-10-31 5:41 pm | N/A 2023-11-21 | EAGLE PHARMACEUTICALS INC. | EGRX | Graves Michael Director | 9,360 | $0 | 10,360 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:04 pm | N/A 2033-03-07 | EAGLE PHARMACEUTICALS INC. | EGRX | RATOFF STEVEN B Director | 16,253 | $0 | 16,253 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:03 pm | N/A 2033-03-07 | EAGLE PHARMACEUTICALS INC. | EGRX | Graves Michael Director | 16,253 | $0 | 16,253 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:02 pm | N/A 2033-03-07 | EAGLE PHARMACEUTICALS INC. | EGRX | Simpson Jennifer K. Director | 16,253 | $0 | 16,253 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:02 pm | N/A 2033-03-07 | EAGLE PHARMACEUTICALS INC. | EGRX | Glenning Robert Director | 16,253 | $0 | 16,253 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:01 pm | N/A 2033-03-07 | EAGLE PHARMACEUTICALS INC. | EGRX | Edlin Richard A. Director | 16,253 | $0 | 16,253 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:01 pm | N/A 2033-03-07 | EAGLE PHARMACEUTICALS INC. | EGRX | BORIO LUCIANA Director | 16,253 | $0 | 16,253 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-02 4:20 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 718 | $28 | 47,868 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:20 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 18,500 | $0 | 47,868 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-02 4:18 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 3,113 | $28 | 1,639,934 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:18 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 70,900 | $0 | 1,639,934 (Direct) | View |
| 2023-02-02 Tax Withholding | 2023-02-06 4:48 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 785 | $34.09 | 30,086 (Direct) | View |
| 2023-01-30 Tax Withholding | 2023-01-31 6:21 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 601 | $33.21 | 30,871 (Direct) | View |
| 2023-01-23 Tax Withholding | 2023-01-24 6:13 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 3,732 | $33.64 | 1,572,147 (Direct) | View |
| 2023-01-05 Tax Withholding | 2023-01-09 4:34 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 734 | $29.26 | 31,472 (Direct) | View |
| 2023-01-05 Tax Withholding | 2023-01-09 4:33 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 3,827 | $29.26 | 1,575,879 (Direct) | View |
| 2022-12-19 Tax Withholding | 2022-12-21 4:17 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 461 | $30.03 | 32,206 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 6:20 pm | N/A 2032-02-28 | EAGLE PHARMACEUTICALS INC. | EGRX | BORIO LUCIANA Director | 11,200 | $0 | 11,200 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 6:11 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer | 10,400 | $0 | 32,115 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 6:09 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 8,000 | $0 | 32,667 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 6:06 pm | N/A 2032-02-28 | EAGLE PHARMACEUTICALS INC. | EGRX | Edlin Richard A. Director | 11,200 | $0 | 11,200 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 6:05 pm | N/A 2032-02-28 | EAGLE PHARMACEUTICALS INC. | EGRX | Simpson Jennifer K. Director | 11,200 | $0 | 11,200 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 6:04 pm | N/A 2032-02-28 | EAGLE PHARMACEUTICALS INC. | EGRX | RATOFF STEVEN B Director | 11,200 | $0 | 11,200 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 6:02 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Tarriff Scott CEO 10% Owner | 34,800 | $0 | 1,579,706 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 5:57 pm | N/A 2032-02-28 | EAGLE PHARMACEUTICALS INC. | EGRX | Graves Michael Director | 11,200 | $0 | 11,200 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 5:57 pm | N/A 2032-02-28 | EAGLE PHARMACEUTICALS INC. | EGRX | Glenning Robert Director | 11,200 | $0 | 11,200 (Direct) | View |
| 2022-02-02 Tax Withholding | 2022-02-04 4:58 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Cahill Brian Joseph Chief Financial Officer | 805 | $45.03 | 24,667 (Direct) | View |
| 2022-02-02 Tax Withholding | 2022-02-04 4:57 pm | N/A N/A | EAGLE PHARMACEUTICALS INC. | EGRX | Moran Michael Shawn EVP, Chief Commercial Officer | 742 | $45.03 | 21,715 (Direct) | View |